Cormorant Asset Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $187M | Sell |
|
|||||
|
2022
Q1 | $99.3M | Buy |
|
|||||
|
2021
Q4 | $144M | Buy |
|
|||||
|
2021
Q3 | $189M | Sell |
|
|||||
|
2021
Q2 | $237M | Buy |
|
|||||
|
2021
Q1 | $260M | Buy |
|
|||||
|
2020
Q4 | $292M | Sell |
|
|||||
|
2020
Q3 | $213M | Sell |
|
|||||
|
2020
Q2 | $177M | Sell |
|
|||||
|
2020
Q1 | $137M | Sell |
|
|||||
|
2019
Q4 | $212M | Sell |
|
|||||
|
2019
Q3 | $133M | Buy |
|
|||||
|
2019
Q2 | $127M | Buy |
|